Assessment of Cardiotoxicity after a Single Dose of Combretastatin A4-Phosphate in Dogs Using Two-Dimensional Speckle-Tracking Echocardiography

SIMPLE SUMMARY: Combretastatin A4-phosphate is a chemotherapeutic drug which has been evaluated for treatment of solid canine tumors. Previous studies reported cardiotoxic effects based on changes in cardiac troponin I measurements, blood pressure, and electrocardiography. We evaluated the cardiotox...

Descripción completa

Detalles Bibliográficos
Autores principales: Mampaey, Gitte, Hellemans, Arnaut, de Rooster, Hilde, Schipper, Tom, Abma, Eline, Broeckx, Bart J. G., Daminet, Sylvie, Smets, Pascale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658292/
https://www.ncbi.nlm.nih.gov/pubmed/36359129
http://dx.doi.org/10.3390/ani12213005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658292/
https://www.ncbi.nlm.nih.gov/pubmed/36359129
http://dx.doi.org/10.3390/ani12213005

Ejemplares similares